In collaboration with Consulting Editor, Dr. Lucky Jain, Guest Editor Dr. Daniel Wechsler has assembled expert authors to provide a current update on the diagnosis and treatment of neonatal malignant disorders. Articles are specifically devoted to the following topics: Genetic Predisposition and Neonatal Cancer; Infant Leukemias; Neonatal Malignant Disorders: Brain Tumors; Retinoblastoma; Neonatal Malignant Disorders: Kidney Tumors; Neonatal Malignant Disorders: Liver Tumors; Neuroblastoma; Neonatal Malignant Disorders: Sarcoma; Neonatal Malignant Disorders: Germ Cell Tumors; Neonatal Histiocytoses; Lymphatic Malformations; and Long-Term Outcomes in Neonatal Cancer Survivors. Readers will come away with the information they need to improve outcomes in infants with neonatal malignant disorders.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. CME Accreditation Page - p. xi 7. Forthcoming Issues - p. xiii 8. Foreword - p. xv 9. Preface - p. xix 10. Cancer Predisposition in Neonates and Infants: Recognition, Tumor Types, and Surveillance - p. 1 11. Neonatal Leukemia - p. 15 12. Neonatal Central Nervous System Tumors - p. 35 13. Neonatal Retinoblastoma - p. 53 14. Neonatal Renal Tumors - p. 71 15. Neonatal Liver Tumors - p. 83 16. Neonatal Neuroblastoma - p. 101 17. Advances in the Diagnosis and Management of Neonatal Sarcomas - p. 117 18. Neonatal Malignant Disorders: Germ Cell Tumors - p. 147 19. Histiocytic Diseases of Neonates: Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, and Juvenile Xanthogranuloma - p. 167 20. Neonatal Vascular Tumors - p. 181 21. Late Effects in Survivors of Neonatal Cancer - p. 199
In collaboration with Consulting Editor, Dr. Lucky Jain, Guest Editor Dr. Daniel Wechsler has assembled expert authors to provide a current update on the diagnosis and treatment of neonatal malignant disorders. Articles are specifically devoted to the following topics: Genetic Predisposition and Neonatal Cancer; Infant Leukemias; Neonatal Malignant Disorders: Brain Tumors; Retinoblastoma; Neonatal Malignant Disorders: Kidney Tumors; Neonatal Malignant Disorders: Liver Tumors; Neuroblastoma; Neonatal Malignant Disorders: Sarcoma; Neonatal Malignant Disorders: Germ Cell Tumors; Neonatal Histiocytoses; Lymphatic Malformations; and Long-Term Outcomes in Neonatal Cancer Survivors. Readers will come away with the information they need to improve outcomes in infants with neonatal malignant disorders.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. CME Accreditation Page - p. xi 7. Forthcoming Issues - p. xiii 8. Foreword - p. xv 9. Preface - p. xix 10. Cancer Predisposition in Neonates and Infants: Recognition, Tumor Types, and Surveillance - p. 1 11. Neonatal Leukemia - p. 15 12. Neonatal Central Nervous System Tumors - p. 35 13. Neonatal Retinoblastoma - p. 53 14. Neonatal Renal Tumors - p. 71 15. Neonatal Liver Tumors - p. 83 16. Neonatal Neuroblastoma - p. 101 17. Advances in the Diagnosis and Management of Neonatal Sarcomas - p. 117 18. Neonatal Malignant Disorders: Germ Cell Tumors - p. 147 19. Histiocytic Diseases of Neonates: Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, and Juvenile Xanthogranuloma - p. 167 20. Neonatal Vascular Tumors - p. 181 21. Late Effects in Survivors of Neonatal Cancer - p. 199
